Research
Patient Access to Biosimilars Is Increasing as Prices Are Decreasing
December 11, 2022
A new research paper from Matrix Global Advisors, Improvements in Medical Benefit Coverage of Biosimilars, finds that commercial medical benefit...
Improvements in Medical Benefit Coverage of Biosimilars
December 11, 2022
To shed light on recent trends in payer coverage of biosimilars, this paper analyzes commercial medical benefit coverage and price...
PBMs Support Patients With Diabetes
December 11, 2022
PBMs negotiate with drug manufacturers to lower costs for diabetes drugs and recommend to plan sponsors and insurers programs to...
PBMs CREATE $145 BILLION IN VALUE TO SOCIETY ANNUALLY
October 11, 2022
A new paper from University of Chicago economics professor Casey Mulligan, The Value of Pharmacy Benefit Management, finds that pharmacy...
With PBMs, Asthma Patients Can Breathe with Ease
September 11, 2022
Financially, asthma costs the U.S. over $50 billion a year in medical costs. Those living with asthma can also rack up much...
PBMs HELP PATIENTS WITH ASTHMA BREATHE EASIER
September 11, 2022
Asthma is a long-term respiratory disease that causes inflammation and swelling in the airways. Twenty-Five million Americans, 1 in every...
The Value of Pharmacy Benefit Management
July 11, 2022
This paper provides a quantitative model consistent with the theory and evidence in which pharmacy benefit management on behalf of...
July 11, 2022
The National Council for Prescription Drug Programs (NCPDP) is a non-profit organization that develops and promotes healthcare industry standards in...
PCMA Statement on New Milliman Report on Insulin Coverage in Medicare Part D
June 22, 2022
Understanding beneficiaries' formulary coverage for insulin products in 2020, 2021, and 2022....
White Bagging Dispensing: Convenient and Less Costly
June 11, 2022
Physician-administered drugs are those administered by a health care provider to a patient through injection or infusion, typically in a...
DATA SHOWS THAT MANUFACTURER DRUG PRICE INCREASES ARE UNRELATED TO PBM NEGOTIATED REBATES
April 11, 2022
Increasing list prices are not correlated with changes in prescription drug rebates....
CBO Report on Prescription Drug Trends
March 11, 2022
A recent CBO report on prescription drug price and utilization trends both emphasized the value of pharmacy benefit managers (PBMs) and confirmed...
